Recall archive / FDA company announcement
Advanced Alkaloids: Alkaloids Chewable Tablets—White Vein — FDA announcement Feb 17, 2026
Published notice; closure not supplied
A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.
Source date Feb 17, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Alkaloids Chewable Tablets—White Vein
- Reason
- Product contains 7-Hydroxymitragynine (7-OH) in an amount more than the declared value of 7.5 mg/tablet.
- Classification
- Not supplied
- Recalling firm
- Shaman Botanicals, LLC
- Quantity
- Not supplied
- Agency-reported status
- Company recall announcement
- Source record identifier
- a3b69c065ff917f4
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | FOR IMMEDIATE RELEASE – February 13, 2026 – North Kansas City, Missouri, Shaman Botanicals, LLC is voluntarily recalling one lot (Lot B# AAW.501.3) of Alkaloids Chewable Tablets—White Vein to the consumer level. Recent testing showed that the Alkaloids Chewable Tablets—White Vein product contains 7-Hydroxymitragynine (7-OH) in an amount more than the declared value of 7.5 mg/tablet.; Shaman Botanicals, LLC has not received any reports of adverse events related to this lot of Alkaloids Chewable Tablets—White Vein.; The product is packaged in a 2-count bag with UPC Code 810057763724, in a 20-count bag with UPC Code 810057763830 and in a 30-count bottle with UPC Code 810057763779. The affected Alkaloids Chewable Tablets—White Vein lot has the following lot number: Lot B# AAW.501.3 (all expiration dates). The product can be identified by the lot number on the package and/or the bottom of the bottle. The Alkaloids Chewable Tablets—White Vein product was distributed nationwide to wholesalers, retailers, and consumers via online sales. |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
The product is packaged in a 2-count bag with UPC Code 810057763724, in a 20-count bag with UPC Code 810057763830 and in a 30-count bottle with UPC Code 810057763779. The affected Alkaloids Chewable Tablets—White Vein lot has the following lot number: Lot B# AAW.501.3 (all expiration dates). The product can be identified by the lot number on the package and/or the bottom of the bottle. The Alkaloids Chewable Tablets—White Vein product was distributed nationwide to wholesalers, retailers, and consumers via online sales.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Fda listing date
- Feb 17, 2026
- Company announcement date
- Feb 13, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.